BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38067149)

  • 1. Common Variants in Osteopontin and
    Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
    Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in
    Butkiewicz D; Krześniak M; Gdowicz-Kłosok A; Giglok M; Marszałek-Zeńczak M; Suwiński R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
    Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
    PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
    Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
    Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
    Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D
    BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
    Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
    BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
    Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
    Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin is a prognostic biomarker in non-small cell lung cancer.
    Rud AK; Boye K; Oijordsbakken M; Lund-Iversen M; Halvorsen AR; Solberg SK; Berge G; Helland A; Brustugun OT; Mælandsmo GM
    BMC Cancer; 2013 Nov; 13():540. PubMed ID: 24215488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of single nucleotide polymorphisms of the osteopontin gene with astheozoospermia].
    Wei YX; Lu YL; Liao BY; Hu LL; Chen XH; Liu ZL; Yang FL; Wang JL
    Zhonghua Nan Ke Xue; 2021 Jun; 27(6):506-512. PubMed ID: 34914289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
    Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
    Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.
    Chen Y; Liu H; Wu W; Li Y; Li J
    J Exp Clin Cancer Res; 2013 Jul; 32(1):45. PubMed ID: 23883434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
    Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
    Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
    Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
    J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
    Wohlleben G; Hauff K; Gasser M; Waaga-Gasser AM; Grimmig T; Flentje M; Polat B
    Oncol Rep; 2018 Jan; 39(1):442-448. PubMed ID: 29115557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
    Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
    Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus.
    Karamizadeh Z; Kamali Sarvestani E; Saki F; Karamifar H; Amirhakimi GH; Namavar Shooshtarian MH; Ashkani-Esfahani S
    J Endocrinol Invest; 2013 Dec; 36(11):1090-3. PubMed ID: 24084141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.